Ex-Genentech staff indicted for JHL help
A federal grand jury has indicted three former Genentech employees and a former JHL Biotech staff member for stealing trade secrets from the originator and funnelling them to the Taiwanese biosimilars player to help it develop biosimilars of four of Genentech’s products: Rituxan (rituximab), Herceptin (trastuzumab), Pulmozyme (dornase alfa), and Avastin (bevacizumab).
You may also be interested in...
Two former JHL Biotech executives have been handed prison sentences after pleading guilty to a charge of conspiracy to commit theft of trade secrets and wire fraud, in relation to the Taiwanese firm’s development of multiple biosimilars.
Pfizer claims two former employees stole trade secrets relating to its diabetes-obesity GLP-1 receptor agonist research program for their startup Regor Therapeutics. Regor’s $1.5bn deal with Lilly further spurred Pfizer’s concerns.
Pfizer alleges its associate director of statistics transferred 12,000 files from her company laptop ahead of move to Xencor. Company seeks a temporary restraining order to prevent her from disclosing confidential information, including information on Pfizer’s COVID-19 vaccine and monoclonal antibodies for treatment of cancer.